Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation
Author(s) -
Demilade Adedinsewo,
Junjun Xu,
Pradyumna Agasthi,
Adesoji Oderinde,
Oluwatoyosi A. Adekeye,
Rajesh Sachdeva,
George Rust,
Anekwe Onwuanyi
Publication year - 2017
Publication title -
circulation arrhythmia and electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.684
H-Index - 102
eISSN - 1941-3149
pISSN - 1941-3084
DOI - 10.1161/circep.116.004573
Subject(s) - digoxin , hazard ratio , medicine , atrial fibrillation , confidence interval , medicaid , proportional hazards model , population , heart failure , cohort , cohort study , retrospective cohort study , cardiology , demography , environmental health , economics , economic growth , sociology , health care
Our study demonstrates an overall increased risk of hospitalizations and mortality with digoxin use but no racial/ethnic differences in outcomes were observed. Further studies including minority populations are needed to critically evaluate these associations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom